Publications

Petousis-Harris H, Poole T, Booy R, Turner N. Fever following administration of two inactivated influenza vaccines – a survey of parents of New Zealand infants and children 5 years of age and under. Vaccine 2011;29:2933-7. [Full text]

Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE, for the PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29:3061-6. [Abstract]

Dierig A, Khandaker G, Booy R. Clinical impact of influenza – lessons learnt from the pandemic influenza A (H1N1) 2009 . Microbiology Australia 2011;32:29-33. [Abstract]

Heywood AE, Macartney KK. How can we better understand trends in varicella zoster virus-related disease epidemiology? [letter] . Medical Journal of Australia 2011;194:268-9. [Abstract]

Foxwell AR, McIntyre P, Quinn H, Roper K, Clements MS. Severe pertussis in infants: estimated impact of first vaccine dose at 6 versus 8 weeks in Australia. Pediatric Infectious Disease Journal 2011;30:161-3. [Abstract]

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD. Reduction in rotavirus associated acute gastroenteritis following introduction of rotavirus vaccine into Australia’s national childhood vaccine schedule. Pediatric Infectious Disease Journal 2011;30(1 Suppl):S25-9. [Abstract]

Booy R, Khandaker G, Heron L, Yin JK, Doyle B, Tudo K, Hueston L, Gilbert GL, MacIntyre CR, Dwyer DE. Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians. Medical Journal of Australia 2011;194:19-23. [Full text]

Khandaker G, Rashid H, Chow MY, Booy R. Statins for influenza and pneumonia [protocol] . Cochrane Database of Systematic Reviews 2011;(1):CD008916. doi:10.1002/14651858.CD008916. [Full text]

Van Damme P, Moiseeva A, Marichev I, Kervyn AD, Booy R, Kuriyakose S, Brockway A, Ng SP, Leyssen M, Jacquet JM. Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study. BMC Infectious Diseases 2010;10:357. [Full text]

Chiu C, Dey A, Wang H, Menzies R, Deeks S, Mahajan D, Macartney K, Brotherton J, Jardine A, Quinn H, Jelfs J, Booy R, Lawrence G, Jayasinghe S, Roberts-Witteveen A, Senanayake S, Wood N, McIntyre P. Vaccine preventable diseases in Australia, 2005 to 2007. Communicable Diseases Intelligence 2010;34 Suppl:ix-S167. [Full text]